Monkey IFN-γ T cell ELISPOT kit - 2-plate

SKU
CT121-B2
All-inclusive ELISPOT kit with reagents and plates (192 determinations).
Species reactivity: rhesus macaque, cynomolgus monkey, pig-tailed macaque, baboon and African green monkey
Format
2-plate
Price
€ 485
Documentation
Data sheet
Manual
SDS
Reactivity
Monkey
Category
T cell ELISPOT
Analyte
IFN-γ
Description
Our ELISPOT kits provide a complete, ready-to-use solution for reliable, high-performance ELISPOT assays. Each kit includes all essential components: coating and detection antibodies, streptavidin-HRP, TMB substrate, blocking stock solution, dilution buffer, Tween-20, and high-quality PVDF ELISPOT plates with lids and adhesive plate covers.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Gene ID
574282
Related Products

References

Authors, et al. Title Journal Year Volume Pages
Souvik Karmakar Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons J Infect Dis 2014 209 1929-40
Souvik Karmakar Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons Vaccine 2014 32 1296-303
Babs Verstrepen Vaccine-induced protection of rhesus macaques against plasma viremia after intradermal infection with a European lineage 1 strain of West Nile virus PLoS One 2014 9 e112568
Gajalakshmi Dakshinamoorthy Evaluation of a multivalent vaccine against lymphatic filariasis in rhesus macaque model PLoS One 2014 9 e112982
Thorsten Demberg Impact of antibody quality and anamnestic response on viremia control post-challenge in a combined Tat/Env vaccine regimen in rhesus macaques Virology 2013 440 210-21
Juan Zapata An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity Virol J 2013 10 52
Patricia Devaux A recombinant measles virus unable to antagonize STAT1 function cannot control inflammation and is attenuated in rhesus monkeys J Virol 2011 85 348-56
Ivonne Nieuwenhuis No difference in Gag and Env immune-response profiles between vaccinated and non-vaccinated rhesus macaques that control immunodeficiency virus replication J Gen Virol 2010 91 2974-84
Weidong Zhang Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine J Infect Dis 2010 201 1105-12
Sridhar Dharmapuri Coadministration of telomerase genetic vaccine and a novel TLR9 agonist in nonhuman primates Mol Ther 2009 17 1804-13